Related Experiment Videos
Tiotropium: a bronchodilator for chronic obstructive pulmonary disease
Heather Somand1, Tami L Remington
1College of Pharmacy, University of Michigan, Ann Arbor, MI 48109-0008, USA.
The Annals of Pharmacotherapy
|July 21, 2005
Summary
Tiotropium bromide is an effective bronchodilator for chronic obstructive pulmonary disease (COPD). This inhaled anticholinergic agent improves lung function and quality of life with once-daily dosing.
Area of Science:
- Pulmonary Medicine
- Pharmacology
Background:
- Chronic obstructive pulmonary disease (COPD) is a progressive lung disease.
- Effective long-term management strategies are crucial for COPD patients.
Purpose of the Study:
- To review scientific literature on the efficacy and tolerability of tiotropium bromide.
- To evaluate tiotropium bromide as a bronchodilator for COPD treatment.
Main Methods:
- Searched MEDLINE and bibliographies for studies on tiotropium bromide (BA 679 BR).
- Included experimental and observational studies focusing on human trials.
- Focused on efficacy and tolerability data.
Main Results:
- Tiotropium bromide demonstrated significant improvements in lung function, dyspnea, and quality of life compared to placebo.
- Reduced exacerbation rates were observed in COPD patients using tiotropium.
- Efficacy was comparable to salmeterol and ipratropium, but with a more convenient dosing schedule.
Conclusions:
- Tiotropium bromide is a recommended long-acting bronchodilator for managing moderate to very severe COPD.
- Its once-daily dosing offers a significant advantage over other anticholinergic agents.
- It is an effective inhaled anticholinergic for chronic COPD management.